Jong Joseph Kim - Feb 26, 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Signature
/s/ Jong Joseph Kim
Stock symbol
INO
Transactions as of
Feb 26, 2022
Transactions value $
-$64,545
Form type
4
Date filed
3/1/2022, 05:38 PM
Next filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +68.8K +5.6% 1.3M Feb 26, 2022 Direct F1
transaction INO Common Stock Tax liability -$64.5K -20K -1.54% $3.22* 1.28M Feb 26, 2022 Direct F2
holding INO Common Stock 817K Feb 26, 2022 By Family Limited Partnership
holding INO Common Stock 33.6K Feb 26, 2022 By Daughter: EK
holding INO Common Stock 33.8K Feb 26, 2022 By Son: JK1
holding INO Common Stock 5.98K Feb 26, 2022 By Spouse
holding INO Common Stock 33.5K Feb 26, 2022 By Son: JK2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -68.8K -33.33% $0.00 138K Feb 26, 2022 Common Stock 68.8K Direct F1
transaction INO Common Stock Option Award $0 +628K $0.00 628K Feb 26, 2022 Common Stock 628K $3.22 Direct F3
transaction INO Restricted Stock Unit Award $0 +469K $0.00 469K Feb 26, 2022 Common Stock 469K Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
F3 The vesting schedule for the 627,700 options is as follows: 156,925 shares vested on February 26, 2022; 156,925 shares will vest on February 26, 2023; 156,925 shares will vest on February 26, 2024; 156,925 shares will vest on February 26, 2025.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.